McKesson Corporation (BMV:MCK)

Market Cap	1.58T
Revenue (ttm)	7.12T
Net Income (ttm)	59.67B
Shares Out	n/a
EPS (ttm)	470.59
PE Ratio	26.43
Forward PE	17.49
Dividend	56.87 (0.46%)
Ex-Dividend Date	Jun 2, 2025

Volume	7
Average Volume	2
Open	12,454
Previous Close	12,403
Day's Range	12,454 - 12,454
52-Week Range	9,490 - 13,954
Beta	0.50
RSI	6.06
Earnings Date	Aug 6, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD